Syndax Pharmaceuticals Inc Capital Reinvestment Ratio
Syndax Pharmaceuticals Inc capital reinvestment ratio. Syndax Pharmaceuticals Inc (SNDX) has a Capital Reinvestment Ratio of 0.00x as of December 2021, meaning it reinvests 0% of its operating cash flow ($100.71 Million) in capital expenditures ($129.00K). Check Syndax Pharmaceuticals Inc (SNDX) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Syndax Pharmaceuticals Inc (2021–2021)
Capital reinvestment ratio of Syndax Pharmaceuticals Inc from 2021 to 2021. This chart tracks Syndax Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore net asset growth rate of Syndax Pharmaceuticals Inc to track the company's year-over-year net asset growth rate.
Syndax Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2021–2021)
Syndax Pharmaceuticals Inc capital reinvestment ratio by year from 2021 to 2021. For the full cash flow conversion analysis, see SNDX cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.00x | $29.13 Million | $129.00K | — |